The results showed that PRS and their monomer compounds had great potential in the treatment of UC and provides a certain basis for futuristic clinical studies on microboitic manipulation as a therapeutic approach for the treatment of various other intestinal diseases. This evidence concerns the gene WNK3 and intestinal disorder.